New Haven, CT Clinical Trials Report — June 2026

For New Haven residents considering participation in clinical research, June 2026 presents a crucial window for a number of studies nearing their enrollment deadlines. While the city currently hosts 823 recruiting clinical trials across 258 research facilities, prompt action is essential for those interested in trials that are closing soon.

Act Now: Opportunities Nearing Their Close

A total of 44 clinical trials in New Haven are slated to conclude within the next 90 days. This urgency is particularly relevant for healthy volunteers, as 7 of these rapidly closing studies are still actively seeking participants without specific health conditions. These trials offer a chance to contribute to medical advancements before their enrollment windows close.

Patients managing specific health conditions also face impending deadlines to join research. Trials focused on various cancers and other conditions are among those with limited time remaining for enrollment. Conditions with trials closing soon include:

• Advanced solid tumor (3 trials)
• AML (2 trials)
• Alcohol use (2 trials)
• Triple negative breast cancer (2 trials)
• Advanced malignant neoplasm (1 trial)
• Advanced breast cancer (1 trial)
• Acute liver failure (1 trial)
• Alcohol-related disorders (1 trial)
• Acute myeloid leukemia (1 trial)

For healthy individuals, 2 trials specifically seeking healthy participants are also nearing their close, offering a final opportunity to contribute to general health research.

New Research Opportunities Emerge

This month, New Haven saw the opening of 3 new clinical trials, a decrease compared to the 13 trials that launched in May 2026. This brings the total number of actively recruiting clinical trials in New Haven, CT, to 823. All 3 of these new trials are drug-focused studies, indicating a continued focus on pharmaceutical development within the city's research landscape.

Notably, all 3 of the new trials launched this month are accepting healthy volunteers, adding to the 100 total trials currently recruiting healthy participants in New Haven. This provides ample opportunity for individuals without specific medical conditions to contribute to scientific discovery.

The new trials this month are sponsored by MODAG GmbH (2 trials) and Pfizer (1 trial), bringing significant industry investment to local research. While there are no new Phase 2/3 drug trials with large enrollment numbers to highlight this month, these new studies still offer valuable opportunities for participation.

New trials this month are exploring a range of conditions, with a strong emphasis on general health and neurological disorders. Conditions for which new trials are recruiting include:

• Healthy adults/volunteers (3 trials)
• Asthma (1 trial)
• Multiple system atrophy (MSA) (1 trial)
• Parkinson disease (1 trial)

Regarding participant eligibility, 2 of the new trials include older adults, ensuring that senior populations have avenues to contribute to medical science. No new trials this month are exclusively for children, females, or males.

New Haven's Leading Research Facilities

New Haven is home to prominent research institutions that consistently conduct a high volume of clinical trials. These facilities are key destinations for individuals seeking to participate in medical research, with the Yale system dominating the local landscape:

• Yale University (250 trials)
• Yale Cancer Center (75 trials)
• Yale University School of Medicine (55 trials)
• Yale New Haven Hospital (52 trials)
• Yale School of Medicine (35 trials)
• Smilow Cancer Center/Yale-New Haven Hospital (24 trials)
• Research Site (17 trials)
• Yale-New Haven Hospital (13 trials)
• Yale (9 trials)
• Connecticut Mental Health Center (9 trials)
• Smilow Cancer Hospital at Yale New Haven (8 trials)
• GSK Investigational Site (8 trials)

These institutions offer a broad spectrum of research, from oncology at Yale Cancer Center and Smilow Cancer Center to diverse medical fields across the various Yale-affiliated sites.

Broadening Your Search: Nearby Connecticut Cities

While New Haven offers a vast array of clinical trial opportunities, individuals may also find options in nearby communities within Connecticut. Cities with active trials include:

• Hamden (4 trials)
• Waterbury (3 trials)
• Stamford (2 trials)
• Bridgeport (1 trial)
• Greenwich (1 trial)
• West Haven (1 trial)

As we move through June, New Haven's robust research community continues to drive medical innovation, offering diverse opportunities for individuals to contribute to the future of healthcare, particularly for those who act quickly on trials nearing their close.